JNJ-1661010
CAS: 681136-29-8
Ref. 3D-GCB13629
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
JNJ-1661010
Description:
JNJ-1661010 is a non-selective, orally active, potent and selective small molecule antagonist of the neurokinin-1 receptor (NK1R). It has been shown to inhibit cancer cell invasion. JNJ-1661010 also inhibits the activation of cb2 receptors by endocannabinoids, which may be useful for the treatment of skin cancer. This drug also demonstrates inhibitory properties on inflammatory diseases and autoimmune diseases. JNJ-1661010 is metabolized in humans by hydroxylation and/or amide hydrolysis. The metabolic products are then excreted in urine and feces.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
365.45 g/mol
Formula:
C19H19N5OS
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
